Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-26

FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for metoprolol succinate from BluePoint Laboratories, allowing continued manufacture of the generic product under an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

SUPPL AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)